Advanced Search

Study Preview



Study Title and Description

Fibrosis progression according to epithelial-mesenchymal transition profile: a randomized trial of everolimus versus CsA.



Key Questions Addressed
3 In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Fibrosis progression according to epithelial-mesenchymal transition profile: a randomized trial of everolimus versus CsA.
Author Rostaing L., Hertig A., Albano L., Anglicheau D., Durrbach A., Vuiblet V., Moulin B., Merville P., Hazzan M., Lang P., Touchard G., Hurault deLigny B., Quéré S., Di Giambattista F., Dubois YC., Rondeau E.
Country Department of Nephrology, Dialysis and Transplantation, Hôpital de Rangueil, Toulouse, France.
Year 2015
Numbers Pubmed ID: 25808994
2324 (internal)

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Comparative Effectiveness of Regimens


Results & Comparisons

No Results found.